Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
SchizophreniaDual DiagnosisSchizoaffective DisorderPsychotic DisorderCannabis Abuse
Interventions
DRUG

Clozapine

Clozapine up to 550mg per day

DRUG

Treatment as usual

Remain on pre-study antipsychotic treatment

Trial Locations (4)

29203

University South Carolina, Columbia

64108

University Missouri, Kansas City

90073

West LA VAHCS, Los Angeles

03101

Mental Health Center of Greater Manchester, Manchester

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

University of Missouri, Kansas City

OTHER

collaborator

VA Medical Center-West Los Angeles

FED

collaborator

University of South Carolina

OTHER

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00498550 - Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual | Biotech Hunter | Biotech Hunter